Abstract
Non-enveloped viruses like poliovirus (PV) have evolved the capacity to spread by non-lytic mechanisms. For PV, this mechanism exploits the host secretory autophagy pathway. Virions are selectively incorporated into autophagosomes, double-membrane vesicles that travel to the plasma membrane, fuse, and release single-membrane vesicles containing virions. Loading of cellular cargo into autophagosomes relies on direct or indirect interactions with microtubule-associated protein 1B-light chain 3 (LC3) that are mediated by motifs referred to as LC3-interaction regions (LIRs). We have identified a PV mutant with a severe defect in non-lytic spread. An F-to-Y substitution in a putative LIR of the nonstructural protein 3CD prevented virion incorporation into LC3-positive autophagosomes and virion trafficking to the plasma membrane for release. Using high-angle annular dark-field scanning transmission electron microscopy to monitor PV-induced autophagosome biogenesis, for the first time, we show that virus-induced autophagic signals yield normal autophagosomes, even in the absence of virions. The F-to-Y derivative of PV 3CD was unable to support normal autophagosome biogenesis. Together, these studies make a compelling case for a direct role of a viral nonstructural protein in the formation and loading of the vesicular carriers used for non-lytic spread that may depend on the proper structure, accessibility, and/or dynamics of its LIR. The studies of PV 3CD protein reported here will hopefully provoke a more deliberate look at the presence and function of LIR motifs in viral proteins of viruses known to use autophagy as the basis for non-lytic spread.
INTRODUCTION
Poliovirus (PV), the prototypical member of the Enterovirus genus of the Picornaviridae family of positive-strand RNA viruses, is among the best-understood viruses (1). While PV has been essentially eliminated from developing countries due to effective vaccination measures, global eradication has yet to be certified (2–5). We have used PV as a model system to understand the enzymology and cell biology of viral genome replication (6–9) because of the more than 50 years of work by dozens of investigators establishing a solid foundation of principles governing PV multiplication (10–13).
The latest emerging principle is that non-enveloped picornaviruses spread preferentially by concealing virions within vesicles and using a non-lytic mechanism instead of a lytic mechanism (14–16). Secretory autophagy is the predominant mechanism for the non-lytic spread of PV and other enteroviruses (17–21). The literature supporting this conclusion has interrogated the extent to which what is known about the cellular mechanism of secretory autophagy and corresponding factors align with the virus-induced pathway (22–25). Very little is known about direct contributions of viral factors to non-lytic spread.
We have identified a derivative of the PV nonstructural protein 3CD that causes a defect in the non-lytic spread of the virus. Using a variety of approaches, including high-angle annular dark-field (HAADF) scanning transmission electron microscopy (STEM), we show that 3CD is required for particle movement from the site of assembly into autophagosomes, proper formation of autophagosomes, and movement of virion-containing autophagosomes from the perinuclear region of the cell to the periphery and beyond. We suggest that one or more LC3-interacting regions of 3CD contribute to its post-genome-replication functions and that the multifunctional properties of 3CD are bestowed by its highly tunable, extraordinary conformational dynamics (26–28).
RESULTS
A post-genome-replication function for PV 3CD protein
The processivity of nucleotides incorporated per binding event by poliovirus RNA-dependent RNA polymerase (PV RdRp), without any accessory factors, is predicted to approach 106 (29). The best empirical evidence shows that PV RdRp can replicate through 3000 bp of dsRNA without dissociating (29, 30). The processivity of reverse transcriptases does not approach these values (31, 32). Accessory factors enabling processivity are generally required for DNA polymerases to exhibit high processivity (33–35). The structural basis for PV RdRp processivity is not known. One hypothesis has been that the intimate interaction between the fingertips and thumb subdomains of the RdRp yields a completely encircled active site that will not readily dissociate from the RNA template once engaged (Fig. 1A).
The interface between the fingertips and thumb subdomains is comprised, in part, of three phenylalanine residues: F30 and F34 from the fingertips and F432 from the thumb (Fig. 1A). We constructed a PV RdRp derivative in which F30 was changed to Y, this derivative is referred to herein as F30Y. Our rationale was that burying the tyrosine hydroxyl and any associated water molecules would destabilize the interface, creating a derivative with only reduced processivity.
We reasoned that an RdRp derivative exhibiting a destabilized interaction with primed-template would not assemble on the primed-template as well as WT RdRp does. Once assembled, the complex would also be predicted to be less stable, causing an increase in the steady-state rate constant for nucleotide incorporation and rate constant for dissociation of the derivative from the primed-template when compared to WT RdRp. Interestingly, the biochemical properties of F30Y RdRp were identical to WT (Fig. 1B). Because our in vitro tests could have been masking a phenotype that would be observed in cells, we engineered the F30Y derivative into a subgenomic replicon to indirectly monitor genome replication after transfection by measuring luciferase activity. This assay also failed to reveal a phenotype for the F30Y RdRp (Fig. 1C). We used a replicon expressing an inactive RdRp (GAA) as a negative control. Luciferase activity produced in this case reflects translation of the transfected RNA without genome replication.
For completeness, we engineered the F30Y change into the viral genome. We did not expect a difference between F30Y PV and WT, but F30Y PV exhibited a small-plaque phenotype when compared to WT (Fig. 1D). This phenotype could reflect a reduction in infectious virus produced and/or a reduction in the efficiency of virus spread. We performed a one-step-growth analysis and monitored the production of infectious virus within cells (cell-associated) and the efficiency with which virus was released from cells (media-associated). WT PV reproducibly produced virus on the order of 109 plaque-forming units (pfu) per mL, with 107 pfu/mL detectable in media by the end of the experiment (panel i, Fig. 1E). In contrast, F30Y PV exhibited a one-log reduction in overall yield of cell-associated virus and three- to four-log reduction in media-associated virus (panel ii, Fig. 1E).
The primary form of the RdRp domain in PV-infected cells is the precursor 3CD (36, 37). Previous studies have implicated this protein as a critical factor for genome replication (38–41) and in steps preceding genome replication, including activation of phospholipid biosynthesis and membrane biogenesis (8, 9). The studies reported above are consistent with 3CD as the mediator of the observed effect and a post-genome-replication function for this protein. It is known that purified 3CD stimulates cell-free synthesis of PV (42) through unknown mechanisms. We expressed and purified the corresponding 3CD derivative (F213Y) but will refer to it as F30Y 3CD to avoid confusion. The F30Y 3CD derivative could not support cell-free synthesis stimulation (Fig. 1F), which is consistent with 3CD as the mediator of the observed biological defect and further supports a role for 3CD after genome replication.
PV 3CD contributes to virion morphogenesis and non-lytic spread
Studies of the enterovirus lifecycle can be synchronized using two inhibitors. First, guanidine hydrochloride (GuHCl) at 2 mM is sufficient to inhibit genome replication by inactivating the ATPase activity of the viral 2C protein (43–45). However, the pioneer round of translation occurs, as the activity of genome-encoded reporters like luciferase can be detected (WT+GuHCl in Fig. 2A). Second, 5-(3,4-dichlorophenyl) methyl hydantoin, referred to herein as hydantoin (H) also targets the viral 2C protein, but impairs virion morphogenesis without any impact on genome replication (WT+H in Fig. 2A) (46, 47), although at concentrations higher than 50 μg/mL, hydantoin can inhibit genome replication (48).
To assess PV spread at the population level, we use a recombinant GFP-expressing PV (49–51) to infect HeLa cells containing a plasma membrane red dye and place these on a monolayer of unstained, uninfected HeLa cells (Fig. 2B). As the primary infection proceeds, we observe the formation of yellow cells (Fig. 2B). As the virus spreads from the yellow cells to the uninfected cells, these cells appear green (Fig. 2B). We have provided a representative movie of PV spread using this assay (Movie S1).
We monitored the number of GFP-positive cells as a function of time for WT PV (PV-WT in Fig. 2C). We observed two phases. The first phase included a lag followed by linear accumulation of GFP-positive cells, with the rate of accumulation approaching a plateau by 15 hours post-infection (hpi) (PV-WT in Fig. 2C). At 15 hpi, a secondary wave of GFP-positive cells accumulated, creating an inflection point that is presumably a reflection of PV spread (PV-WT in Fig. 2C). That this second phase represented PV spread was supported by the sensitivity of this phase to the presence of hydantoin in the media (PV-WT+H in Fig. 2D).
We performed the same experiment using F30Y PV. We observed a linear accumulation of GFP-positive cells over the entire 30-h time course (PV-F30Y in Fig. 2C). The observed accumulation was not impacted by the presence of hydantoin (PV-F30Y+H in Fig. 2D), suggesting a slow rate of infection establishment and a substantial defect to and/or delay in virus assembly and/or virus spread.
To investigate virus assembly, we used two monoclonal antibodies: A12 (human) (52) and mAb234 (mouse) (53, 54). The epitope recognized by A12 is in the canyon and should be able to recognize assembled particles whether the viral genome has been encapsidated or not (Fig. 2E) (52, 55, 56). On the other hand, mAb234 binds to the rim of the canyon and should favor binding to a viral genome-containing particle, the virion (Fig. 2E) (54, 57, 58). We used these antibodies to assess infected cells at 6 hpi in the absence and presence of hydantoin (Fig. 2F). For WT PV, mAb234 exhibited the greatest reactivity, consistent with the presence of primarily infectious virions at this time point (WT in Fig. 2F and Fig. S2A, C). In the presence of hydantoin, however, A12 exhibited the greatest reactivity, consistent with hydantoin interfering with encapsidation of the viral genome to form infectious virions (WT+H in Fig. 2F and Fig. S2A, C). Importantly, F30Y PV appears to have no problem making infectious virions based on the accumulation of mAb234-reactive virions as observed for WT (F30Y in Fig 2F and Fig. S2B, C). However, the localization of the virions appears to be restricted to the perinuclear regions compared to WT PV (F30Y in Fig. 2F). Hydantoin also interfered with the maturation of the virus produced by F30Y PV (F30Y+H in Fig. 2F and Fig. S2B, C).
We have developed a system to isolate cell pairs in nanowells and to monitor the spread of infection from an infected to an uninfected cell. This system will be described in detail in a separate report based on a previous design we published (51, 59). To distinguish primary from secondary infections, recipient uninfected cells were stained with a red dye. In these experiments, a UnaG reporter was used instead of GFP (Fig. 2G). The infected cell is introduced into a chamber with an uninfected cell, and infection dynamics are monitored in each cell by measuring green fluorescence evolution (Fig. 2G). A movie illustrating the experiment and outcomes has been provided (Movie S2). Three outcomes can be observed: no spread, lytic spread, and non-lytic spread (Fig. 2G, H). In a no-spread scenario, the infected cell lyses, but the released virus fails to establish infection in the uninfected cell.
We performed a single-cell-pairing experiment using two cell lines: HeLa and HAP1. Observations with each were essentially identical. The primary route of secondary infection for WT PV was by a non-lytic mechanism (non-lytic spread in Fig. 2I). The vast number of lytic infections for WT PV failed to result in secondary infections (compare no spread to lytic spread in Fig. 2I). Interestingly, F30Y PV was significantly and selectively impaired in its ability to spread by a non-lytic mechanism (Fig. 2I). Also interesting was the observation that loss of non-lytic infection led not to more lytic infections that spread but to more lytic infections that failed to spread (Fig. 2I).
PV 3CD comigrates with virions from the perinuclear region of the cell to the periphery
Experiments shown in Fig. 2F above suggested a trafficking defect for virions produced by F30Y PV. We investigated this possibility directly, as indicated in Fig. 3A. We infected HeLa cells in the absence or presence of hydantoin and used immunofluorescence to monitor virus particles/virions and 3CD as a function of time post-infection. The specificity of the antibodies used is indicated by the absence of staining in mock-infected cells (Fig. 3B).
At 4 hpi for WT PV, immature particles predominated (A12 staining exceeds mAb234 in WT 4 hpi column of Fig. 3C). 3CD protein was detected easily and colocalized with virus particles (MERGE in WT 4 hpi column of Fig. 3C). We quantified the staining by each antibody as a function of distance from the perinuclear region of the cell to the periphery (Fig. 3D). This analysis confirmed colocalization of 3CD proteins and particles (WT 4 hpi in Fig. 3D).
At 6 hpi for WT PV, virions predominated (mAb234 staining exceeds A12 in WT 6 hpi column of Fig. 3C). 3CD continued to colocalize with virions (MERGE in WT 6 hpi column of Fig. 3C). However, the peak of fluorescence for both virions and 3CD shifted away from the perinuclear region of the cell towards the periphery (WT 6 hpi in Fig. 3D). By 8 hpi for WT PV, most of the virions were no longer in the cell (WT 8 hpi column in Fig. 3C). Any residual staining of virus particles/virions occurred in the perinuclear regions of the cell (WT 8 hpi in Fig. 3D). The level of 3CD observed in the cell at 8 hpi was also diminished (compare 3CD at 6 hpi to 8 hpi in Fig. 3C).
Immature virus particles do not move to the cell periphery
Hydantoin treatment is thought to trap an intermediate during genome encapsidation (46, 47), likely in association with the replication organelle (21). In the presence of hydantoin, immature particles accumulate and remain associated with the perinuclear region of the infected cell over the entire eight-hour period observed (A12 and mAb234 in columns WT+H 4, 6, 8 hpi of Fig. 3E). 3CD protein colocalized with virus particles and also failed to move to the periphery of the cell over the entire eight-hour period observed (3CD and MERGE in columns WT+H 4, 6, 8 hpi of Fig. 3E). Interestingly, removal of hydantoin followed by fixation 45 min later demonstrated a synchronous exodus of virions and some 3CD as well (WASH in Fig. 3E; compare WT+H 8 hpi to WASH in Fig. 3E).
PV 3CD contributes to virion trafficking
We evaluated F30Y PV (Fig. 4) using the same series of experiments described immediately above for WT PV (Fig. 3). Despite the accumulation of mature virions, there is no detectable movement of the virions or 3CD from the perinuclear region to the periphery of the cell (Figs. 4A, B). The trafficking defect observed is similar to that observed in the presence of hydantoin (compare Fig. 4A to Fig. 4C). Unlike observed for WT PV, hydantoin block release did nothing to synchronize events related to egress (WASH in Fig. 4C). The failure of 3CD to leave the cell in the absence (3CD F30Y 8 hpi of Figs. 4A, B) or in the presence (3CD F30Y+H 8 hpi and WASH of Figs. 4C, D) of hydantoin suggest that it is not the mere duration of infection and corresponding cytopathic effect permeabilizing the cell to permit release of virions and/or 3CD protein.
PV 3CD is required for colocalization of PV virions with lipidated LC3B
It is becoming increasingly clear that non-enveloped viruses like PV, other enteroviruses, and even more distantly related picornavirus family members move from one cell to another by non-lytic mechanisms (14, 16, 60). For PV and the other enteroviruses, secretory autophagy represents the most likely pathway used for virus spread (19–21, 61). For cellular homeostasis, this mechanism requires the correct cellular circumstance to exist for activation of a signaling cascade that leads to the formation of the site of assembly of autophagic vesicles, the so-called omegasome (Fig. 5A) (62–64). Cargo is recruited to the omegasome by a combination of factors, including microtubule-associated protein 1B-light chain 3 (LC3B) and adaptor proteins like sequestosome (SQSTM1/p62), which promotes even more selective cargo loading (65–68). Modification of LC3B with phosphatidylethanolamine produces a lipidated form referred to as LC3B-II (Fig. 5B). LC3B-II located within the omegasome recruits cargo proteins containing LC3-interacting regions (LIRs) (Fig. 5C). Cargo loading elongates the omegasome into a larger double-membraned structure that is ultimately sealed to produce an autophagosome (Fig. 5A) (62, 63, 66, 69–72). In secretory autophagy, autophagosomes move to the periphery of the cell, where they can fuse with the plasma membrane to release cargo enclosed within a single-membrane vesicle (Fig. 5D)(73–75).
We hypothesized that the ability of particles to be loaded into autophagosomes was impaired for F30Y PV. From qualitative (Fig. 5E) and quantitative (Fig. 5F) perspectives, none of the early steps of PV-induced autophagic signals were changed for the mutant virus, including LC3B lipidation or SQSTM1/p62 cleavage. The use of GuHCl permitted assessing virus-induced changes triggered by proteins produced during the pioneer round(s) of translation of the viral genome (+GuHCl in Figs. 5E, F) (44, 45).
By monitoring the colocalization of virions with LC3B-II as a function of time post-infection, we observed a strong colocalization for WT PV (Fig. 5G). There was a strong correspondence in fluorescence intensity patterns from the perinuclear region to the periphery of the cell for virions and LC3B-II, consistent with virions being moved to the cell periphery in autophagosomes or more complex structures, for example, amphisomes (Fig. 5H) (62, 75–77). In contrast, the colocalization of virions with LC3B-II for F30Y PV was, at best, weak, if it occurred at all, either at the level of overlap of the intracellular fluorescence (Fig. 5I) or when monitoring the pattern of fluorescence intensity (Fig. 5J).
Virions produced by both WT and F30Y PV colocalize with GABARAP
LC3 paralogues are collectively referred to as mammalian autophagy-related 8 (Atg8) family members, with Atg8 referring to the yeast orthologue. One paralogue implicated in non-lytic spread by PV is GABA Type A Receptor-Associated Protein (GABARAP), but insufficient data exist to attribute such a function to GABARAP definitively (21, 71, 78).
For WT PV, virions and GABARAP colocalized over the timeframe evaluated and moved from the perinuclear region to the periphery of the cell (Fig. 6A). The observed colocalization was confirmed by quantitative evaluation of the pattern of fluorescence intensity (Fig. 6B). While F30Y PV caused accumulation of both virions and GABARAP in the perinuclear region (Fig. 6C), colocalization of these proteins was not reduced substantially in the presence of the 3CD derivative (Fig. 6D).
Application of high-angle annular dark-field (HAADF) scanning transmission electron microscopy (STEM) to the study of PV-induced autophagic signals
As discussed above, PV non-lytic spread almost certainly hijacks the secretory autophagy pathway (19). However, conventional transmission electron microscopy (TEM) has yet to yield high-resolution images of membrane-associated or vesicular intermediates, no matter how the cells are processed (8, 22, 79). We have used high-angle annular dark-field (HAADF) scanning transmission electron microscopy (STEM) on a 200 kV instrument. HAADF STEM affords good mass contrast without standard TEM staining (Fig. S1).
We focused first on analyzing PV-infected cells at 6 hpi, a time in which virion morphogenesis should be complete and trafficking of particles to the cell periphery should be in progress. In contrast to conventional TEM, electron density appears white in images collected using HAADF STEM. Even at the lowest magnification, we observed vesicular structures filled with electron density (1 μm in Fig. 7A) that improved in resolution as the magnification increased (500 nm and 100 nm in Fig. 7A). At the highest magnification, we observed double-membrane vesicles containing virus particles. By surveying multiple cells, we collected images consistent with steps of the secretory autophagy pathway (Fig. 7B) as illustrated in Fig. 7C: omegasomes, autophagosomes, and amphisome-like vesicles containing virions.
In the presence of hydantoin, omegasomes and autophagosomes formed (Fig. 8A). However, these structures were either devoid of cargo based on the absence of electron density or contained an unknown fibrous material that did not exhibit strong electron density (Fig. 8A). These latter structures were also visible during normal infection in the absence of hydantoin (Fig. 7B).
Interestingly, F30Y PV exhibited a unique phenotype. Omegasomes accumulated (Fig. 8B). Few vesicular structures containing virions existed (Fig. 8B). When virions were loaded into omegasome-like structures, potentially derived from a replication organelle precursor, these failed to close and form autophagosomes (Fig. 8B). A large number of empty, single-membrane vesicles were also present in the perinuclear region of the cell (Fig. 8B).
Together, these observations suggest at least two independent functions of 3CD in autophagic vesicle formation used for non-lytic spread. First, 3CD contributes to omegasomes closure to form autophagosomes (Fig. 8C). Second, 3CD contributes to loading of virions into omegasomes/autophagosomes, likely in an LC3II-dependent manner (Fig. 8C). Both of these 3CD activities are impaired in the F30Y derivative. Further validating this claim is the observation that 3CD protein can be recovered from inside virus-containing vesicles isolated from the supernatant of virus-infected cells (80).
LC3- and GABARAP-interacting regions in PV 3CD
The apparent loss of interaction between LC3B-II and virions in the presence of F30Y 3CD (Fig. 5E) prompted us to evaluate the presence of an LC3-interacting region (LIR) in 3CD. We used the iLIR Database algorithm to search for the LIR consensus: (W/F/Y)-(X)-(X)-(L/I/V) (81). We identified 13 putative LIRs in the 3C and 3D domains of 3CD (Fig. 9A). Interestingly, F30 defines the first amino acid of an LIR consensus motif, and this motif is conserved across enteroviruses (Fig. 9B).
To ask whether or not any of the LIRs could interact with LC3 or GABARAP, we performed a computational docking experiment (82, 83). This experiment identified the region between 216–221 of 3D as capable of interacting with LC3 (Fig. 9C) and GABARAP (Fig. 9D) in the natively folded protein but not the region between 28–33. Performing the same experiment with 3C revealed no interaction with LC3 (Fig. 9E) or GABARAP (Fig. 9F) mediated by a predicted LIR. However, an interaction was observed in these experiments. Assessment of the relevance of this interaction, if at all, will require additional experiments.
The preceding analysis failed to explain a defect associated with the F30Y substitution. We know that 3CD exhibits substantial conformational dynamics (26, 28, 84). We reasoned that a conformation may exist to permit an interaction between the 28–33 LIR of 3D that the F30Y substitution might disrupt. To test this possibility, we docked the 28–33 (WT and F30Y) and 216–221 peptides of 3D to the LIR-binding sites of LC3 and GABARAP (Fig. 9G) (82, 83). We calculated the corresponding values for their equilibrium dissociation constants (Kd) (Fig. 9H). This analysis showed that 216–221 LIR bound more tightly to LC3 and GABARAP than the 28–33 LIR. However, the F30Y substitution increased affinity for LC3/GABARAP rather than decreased it.
As a final approach to obtain insight into the biochemical/biophysical basis for the defect associated with the F30Y substitution, we performed a molecular dynamics simulation of PV 3CD and the F30Y derivative (Fig. 10). PV 3CD is comprised of two domains separated by an interdomain linker and exhibits substantial conformational heterogeneity when comparing the orientation of one domain to that of the other (26, 28, 84). The 3C domain of the derivative was in a different location for the F30Y derivative (Fig. 10A). This difference is likely not meaningful. However, some of the more subtle conformational differences, reported as RMSD, may have some relevance (Fig. 10B). For example, the 28–33 LIR had a clear conformational difference (Fig. 10C) that did not occur with the 217–221 LIR (Fig. 10D). Moreover, residues across the entire protein exhibited significant changes in the 2.5 – 3.5 Å2 range because of the single Phe-to-Tyr change (Fig. 10E). Such changes suggest an allosteric connection between the 28–33 LIR and other regions of the protein that could be responsible for the phenotype observed here.
DISCUSSION
It is now widely believed that dissemination of animal non-enveloped viruses from one cell to another or from one organ/tissue to another exploit virus-repurposed, vesicular carriers of the cell to produce “quasi-enveloped” or “vesicle-cloaked” virions (14, 16, 60, 85). Such a mechanism limits cell lysis and the enormous inflammatory response that would ensue if a lytic mechanism of spread were obligatory. This mechanism also increases the multiplicity of virions initiating an infection (86). Selective, secretory autophagy appears to be the primary mechanism used by enteroviruses (13, 19–21). Since the earliest suggestion that autophagy contributes to enterovirus multiplication (87), many studies have focused on visualizing the double-membrane carriers in infected cells and evaluating the extent to which the normal cellular autophagy pathway and corresponding factors contribute to virus-induced autophagic signals (18, 21, 24, 88, 89). Only a few studies implicate an enteroviral protein(s) in the pathway enteroviruses use for non-lytic spread (24, 89, 90). Here, we report studies designed to probe the structure-function relationships governing processive RNA synthesis by the poliovirus (PV) RNA-dependent RNA polymerase (RdRp) that identified a derivative of the PV nonstructural protein 3CD that substantially reduced PV spread (Fig. 1), especially non-lytic spread (Fig. 2). The goal of this study therefore became focused on elucidating the step(s) post-genome replication requiring 3CD that ultimately leads to reduced, non-lytic spread.
The intracellular, post-genome-replication steps of the enterovirus lifecycle are the least understood. However, studies from several laboratories published over the past decade or so provide a framework for these late lifecycle steps when considered together (16, 19, 23). PV infection induces the formation of membrane tubules that are thought to support genome replication (8, 91, 92). As genome replication ends, these tubules morph into membranous assemblies that appear as vesicular-tubular clusters when cross-sections are imaged using electron microscopy (8, 90, 93). The enteroviral nonstructural protein 2(B)C is a member of the helicase superfamily 3 (94–96). This protein assembles into hexameric rings (96) and brings membranes together (90), potentially creating a channel through which the viral genome can be translocated from within the array of virus-induced membranes to the cytoplasm (90, 97). When processed capsid precursors accumulate to a sufficient level, functional intermediates form, perhaps half capsids (46), that may be localized to the 2(B)C channels by interactions of the capsid protein, VP3, with 2(B)C (98, 99). Empty capsids may then be filled with genomic RNA to produce virions. Virions are trafficked selectively into autophagosomes; empty capsids are excluded (21). Loading of virions into autophagosomes requires microtubule-associated protein 1B-light chain 3 (LC3B) and/or GABA Type A Receptor-Associated Protein (GABARAP) (18, 19, 21). The virion, 2(B)C, and 3CD can be pulled down in association with LC3 (24). Once in autophagosomes, cloaked virions traffic to the cell periphery and are ultimately released from cells in single-membrane vesicles after autophagosomes (or amphisome-like vesicles) fusion with the plasma membrane (19, 100).
Our data suggest that PV 3CD protein contributes to the last three steps described above. These steps are (1) movement of particles from the site of assembly into autophagosomes; (2) proper formation of autophagosomes; and (3) movement of autophagosomes containing PV virions from the perinuclear region of the cell to the periphery.
Using antibodies with some capacity to distinguish between empty capsids and virions, we were able to use immunofluorescence analysis of WT PV-infected cells to monitor spatiotemporal changes during morphogenesis (Fig. 3). By 4 hpi, empty particles had accumulated in the perinuclear region of the cell (WT 4 hpi in Figs. 3C,D), transitioning to virions by 6 hpi (WT 6 hpi in Figs. 3C,D). Once matured, virions moved from the perinuclear region of the cell to the periphery (WT 6 hpi in Figs. 3C, D). 3CD protein tracked with virus particles, moving from the perinuclear region of the cell to the periphery (WT 4 hpi and 6 hpi in Figs. 3C, D). We did not observe 3AB protein movement (data not shown). By 8 hpi, levels of virions and 3CD diminished substantially, consistent with both being released from the cell (WT 8 hpi in Figs. 3C, D). Although particle maturation occurred normally for F30Y PV, at least as measured by immunofluorescence, virions, and 3CD were trapped in the perinuclear region of the cell (Figs. 4A, B). We suggest the existence of a physical interaction between 3CD and virions that facilitates virion incorporation into vesicular carriers used for non-lytic spread.
Both WT and F30Y PVs appeared identical in their ability to induce autophagic signals based on LC3 lipidation and cleavage of an LC3 adaptor protein (Figs. 5E, F). For WT PV, we observed a clear colocalization of LC3 with virions (Figs. 5G, H) and 3CD protein, based on the association of virions and 3CD shown above (Figs. 3C, D). This colocalization was maintained from the perinuclear region at 4 hpi (Figs. 5G, H) to the periphery at 6 hpi (Figs. 5G, H). The association was no longer detectable, most likely because of the release of vesicular carriers of the virus that presumably also contained 3CD. For F30Y PV, colocalization of LC3 with virions and 3CD was lost (Figs. 5I, J). These data are consistent with our proposition that an interaction between virions and 3CD delivers virions into LC3-marked vesicles. The 3CD derivative cannot facilitate virion loading. Interestingly, GABARAP-mediated loading of virions appeared unaffected for F30Y PV, suggesting the existence of two independent mechanisms for non-lytic spread (Figs. 6C, D). Two mechanisms would also explain our observation that not all non-lytic spread was eliminated for F30Y PV (Fig. 2H).
We have used high-angle annular dark-field (HAADF) scanning transmission electron microscopy (STEM) on a 200 kV instrument for the first time to monitor PV-infected cells which may represent its first use in characterizing virus-infected cells. HAADF STEM permitted us to visualize all of the intermediates and products expected for a virus using secretory autophagy for non-lytic spread (Fig. 7). Virion formation was not essential for formation of autophagosomes as they formed in the presence of hydantoin (Fig. 8A). However, the 3CD derivative prevented formation of membranous structures expected if the sole defect were related to virion loading (Fig. 8C). We suggest a role for 3CD in virus-induced autophagosome biogenesis independent of its role in virion loading.
LC3-interacting regions (LIRs) are predicted in all four capsid protomers (Fig. S2) and 3CD (Fig. 9A). Capsid, 2(B)C and 3CD proteins coprecipitate with LC3 (24). Interestingly, there is an LC3 epitope located at the cleavage site between VP4 and VP2 of the VP0 capsid precursor that interacts with the LC3 adaptor protein SQSQTM1/p62 and may be capable of interacting with other LIR-containing proteins (89). Viral LIRs may mediate capsid-LC3 or capsid-3CD-LIR interactions required for virion loading. F30Y increased the affinity of this highly conserved LIR (Fig. 9H) and perturbed the local conformations of both the 28–33 and 216–221 LIRs (Fig. 10). Such conformational changes may interfere with 3CD-dependent loading. These conformational changes may also interfere with autophagosome formation in the absence of cargo loading by preventing cargo-independent interactions of 3CD with LC3.
If one listed the function of 3CD protein 20 years ago, at the top of the list, functions related to its protease activity or its viral RNA-binding properties would appear (101). Over the past two decades, it has become clear that 3CD has many functions before genome replication related to its phospholipid-binding activity (8, 9, 102). These include the ability to induce phosphatidylinositol-4-phosphate and phosphatidylcholine synthesis and membrane biogenesis, which are presumably required to form the organelles for genome replication and virus assembly (8, 9, 91). Here, we have uncovered 3CD contributions after genome replication. The determinants of 3CD underpinning these functions need to be clarified but may include its LIRs. A much more deliberate analysis of LIRs encoded by enteroviruses is warranted. The ability of 3CD to exhibit so many diverse functions is likely related to the extraordinary conformational dynamics of this protein (26, 28, 84) and the sensitivity of these dynamics to even single amino acid substitutions, as shown here (Fig. 10). Together, this study highlights a crucial example of how LIR and LIR-like sequences in the viral genome play a significant role in hijacking components of the autophagy pathway to multiply and spread and underscores the importance of further exploring these sequences in other viral proteins and their potential function in a multitude of viruses with similar mechanisms.
MATERIALS AND METHODS
Cells and cultures
HeLa cells (CRM-CCL-2) were purchased from the American Type Culture Collection (ATCC) and grown in Dulbecco’s Modified Eagle Medium: Ham’s nutrient mixture F-12 (DMEM:F12) (Gibco). HAP1 human near-haploid cells were purchased from Horizon Discovery Group (Horizon) and grown in Iscove’s Modified Dulbecco’s Medium (IMDM). All cell lines were supplemented with 10% heat-inactivated fetal bovine serum (HI-FBS) (Atlanta Biologics), 1% of a penicillin and streptomycin mixture (P/S) (Corning), and maintained at 37° C and 5% CO2.
Viruses
Wild-type and recombinant viruses were recovered following in vitro transcribed RNA transfection in HeLa cells. RNA was produced from full-length cDNA as described in the “Plasmids, in vitro transcription, cell transfection, and virus quantification” section. PV type 1 (Mahoney) was used as our WT PV strain throughout this study. The virus was quantified by standard plaque assay methods yielding virus titers (pfu/mL).
Antibodies
The following commercially available and in-house produced antibodies were used at the specified dilutions in this study: human monoclonal A12 (gift from the Altan-Bonnet and Amy Rosenfeld Labs) (1:10,000 or 1:1500), mouse monoclonal Mab234 (gift from Andrew McAdam) (1:800), rat polyclonal PV 3CD (1:800), rabbit polyclonal PV 3AB (1:800), rabbit polyclonal PV VP2 (Cameron) (1:1000), rabbit monoclonal LC3B-D11 (Cell Signaling) (1:200), mouse monoclonal LC3B (Cell Signaling) (1:100), GABARAP monoclonal (Cell Signaling) (1:100), GABARAP monoclonal (ProteinTech), SQSTM1/p62 rabbit (Cell Signaling) (1:1000), rabbit αTubulin (Cell Signaling) (1:1000). Antibodies against PV 3D and 3AB were produced in Cameron Lab. All secondary antibodies goat anti- (human, mouse, rat, or rabbit) (H+L) used for immunofluorescence (1:1000) were purchased from Invitrogen. Secondary antibodies for western blotting: rabbit anti-HRP (Amersham GE Healthcare) and mouse anti-HRP (Cell Signaling).
Reagents
Where specified, guanidine hydrochloride (GuHCl) (Sigma) was added to growth medium at 3 mM to inhibit PV genome replication, and 5-(3,4-dichlorophenyl) methylhydantoin (hydantoin) (Enamine) at 50 μg/mL to inhibit post-replication steps of PV infection.
Plasmids, in vitro transcription, cell transfection, and virus quantification
Subgenomic WT and replication-incompetent GAA PV replicons were previously described (37). All insertions/deletions were produced using overlap extension PCR or gBlock gene fragments from Integrated DNA Technologies (IDT). Desired insertions/deletions or mutations in the PV cDNA were verified by DNA sequencing. For PV unaGpv, the unaG-coding sequence was embedded between the 2C/3A coding region. The unaG-encoding sequence contained a 3C protease cleavage site at its carboxyl terminus for proteolytic cleavage/release of unaG protein engaged by 3C protease activity. Plasmids encoding PV genomes (full-length or subgenomic) were linearized using an ApaI restriction enzyme site.
All linearized cDNAs were in vitro transcribed using a T7 RNA polymerase produced in Cameron Lab and treated with 2 units of DNAse Turbo (ThermoFisher) to remove the residual DNA template. The RNA transcripts were purified using RNeasy Mini Kit (Qiagen) before spectrophotometric quantification. Purified RNA in RNase-free H2O was transfected into cells by electroporation using a Bio-Rad instrument (Gene Pulser).
Virus yield was quantified in HeLa cells by plaque assay. Cells and/or supernatant media were harvested post-transfection or infection at the specified time points, subjected to three freeze-thaw cycles, and clarified by ultracentrifugation. The supernatant was seeded on a fresh HeLa cell monolayer in 6-well plates and incubated at room temperature for 30 min before rinsing with 1X PBS. Then, a 1% (w/v) low-melting agarose/media overlay was added. Cells were incubated for either 2 days using WT PV or 3 days using F30Y PV, then fixed and stained using a PFA-containing crystal violet solution. Plaques were quantified to yield a PFU/mL titer.
PV RdRp Biochemical characterization
Reactions were performed essentially as described in (29). All reactions contained 25 mM HEPES pH 7.5, 5 mM MgCl2, 10 mM BME, 60 μM ZnCl2, and 50 mM NaCl. Reactions were performed at 30 °C. Reactions were quenched by adding EDTA to a final concentration of 50 mM. An equal volume of loading buffer (90% formamide, 0.025% bromphenol blue, and 0.025% xylene cyanol) was added to quenched reactions, and products were resolved from substrates by denaturing PAGE and visualized by using a PhosphorImager (GE) and quantified by using ImageQuant TL software (GE). For all reactions, the formation of 11-mer product RNA was monitored. Kinetics of complex assembly: Reactions contained 2 μM primed-template RNA substrate S/S-U (1 μM duplex), 500 μM ATP, and 1 μM PV RdRp. Reactions were initiated by adding PV RdRp and quenched at various times. Active site titration: Reactions contained 20 μM primed-template RNA S/S-U (10 μM duplex), 500 μM ATP, and 2 μM PV RdRp. Reactions were initiated by adding PV RdRp and quenched at various times. Kinetics of complex dissociation: 2 μM PV RdRp was incubated with 5’-P-labeled S/S-U (1 μM duplex) for 90 sec to assemble enzyme-RNA complex, then, unlabeled S/S-U (trap) was added to a final concentration of 100 μM. At various times after the addition of trap RNA, the amount of complex remaining was determined by taking a reaction aliquot and rapidly mixing it with an equal amount of 1 mM ATP. After mixing with ATP, the reactions were allowed for 30 sec and quenched.
Sub-genomic replicon luciferase assay
Subgenomic replicon luciferase assays were performed as described previously (8). Subgenomic replicon RNA (5 μg of in vitro transcribed RNA) was electroporated into HeLa cells. The cells were incubated in standard growth media (DMEM/F12 supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin; cells were harvested and lysed using 100 μL of 1X cell culture lysis reagent (CCLR, Promega) at the indicated times post-electroporation. Luciferase was measured as a surrogate for genome replication using a relative light unit (RLU) normalized to protein content (μg) from an absorbance measure of the collected lysates. Luciferase activity was measured by adding an equal volume of firefly luciferase assay substrate (Promega) to cell lysates and measured in a Junior LB 9509 luminometer (Berthold Technologies) or a BioTek plate reader.
Plaque assay comparing plaque forming unit phenotypes
HeLa cell monolayers were infected with 50 plaque-forming units (PFU) using WT or F30Y PV. Cells were then incubated at 37 °C for three days ahead of staining with crystal violet for plaque quantification and phenotype assessment.
One-step growth curve of media-associated and cell-associated viruses
HeLa cell monolayers were infected with WT or F30Y PV at an MOI of 10. The virus was then collected from the supernatant and cells (independently) at the indicated time points. Media-associated (supernatant) and cell-associated (cells) virus titer was determined by plaque assay.
Cell-free PV synthesis supplemented with purified 3CD protein
Cell-free PV synthesis experiments were carried out as described by Franco et al. (2005). HeLa cytoplasmic extracts (cell-free) were supplemented with viral RNA as a translation template in the presence of unlabeled methionine, 200 μM each CTP, GTP, UTP, and 1 mM ATP. Exogenous purified WT or F30Y PV 3CD protein was introduced to the reaction. After a 12–15 hr incubation, samples were diluted with phosphate-buffered saline and applied to HeLa cell monolayers. Virus titers were determined by plaque assay.
Bulk spread assays
HeLa cells in suspension were stained using a membrane dye Vybrant DiD (Molecular Probes) and infected with a green fluorescence PVeGFPpv reporter variant at an MOI of 5. Infected/dyed cells (red) were seeded on top of a naïve HeLa cell monolayer. Fluorescence is monitored over time to detect both primary and secondary infections. Primary infected cells were observed and depicted in yellow when green (eGFP expression) and red signal (cell dye) colocalized in overlays. Spread was detected when a secondary wave of PV green fluorescence signal (green only) originating from the newly infected monolayer of unstained cells was observed.
For imaging, the plate was placed in the chamber of a WSKM GM2000 incubation system (Tokai, Japan), which was adapted to a Nikon Eclipse Ti inverted microscope (Nikon, Japan). Automatic bright-field and fluorescence imaging were performed every 30 minutes from 3 to 24 hpi with a ProScan II motorized flat top stage (Prior Scientific, USA), a CFI60 Plan Apochromat Lambda 10× objective, and a Hamamatsu C11440 camera. Image analysis was performed using the ComDet module. Cells were quantified as GFP or Red Dye positive given a fluorescence intensity threshold; the number of green cells was normalized to the initial fraction of GFP-positive cells and plotted.
Immunofluorescence assays
HeLa cells were grown in coverslips, treated as described in the respective figures, and fixed at the specified time points using 4% formaldehyde in PBS for 20 min. Immunostaining was performed by permeabilizing with 0.2% Triton X for 10 min, blocking with 3% Goat Serum in PBS for 1 hour, and incubating in primary antibodies for 1 hour. Following washes, cells were incubated with secondary antibodies for 1 hour and either DAPI (Sigma) or TOPO-3 (Invitrogen) for 10 mins. The processed coverslips were mounted on glass slides using ProLong Glass Antifade Mountant (Thermo Scientific).
Imaging was performed using an oil immersion 63X objective on the Zeiss 880 confocal microscope at the Hooker Imaging Core at UNC. Images were acquired and minimally processed using the Zeiss Zen software. Multiple images were obtained, and a representative cell was selected from representative image fields.
Fluorescence intensity profiles
A white line extending from the nuclear envelope to the plasma membrane of cells was drawn for “profile fluorescence” signal quantification. Intensity profile measurements were taken from regularly spaced points along a line segment to depict the spatial and temporal dynamics of fluorescence reactivity, levels, and signal overlap in infected cells over time, using the “Profile” module in the Zeiss Zen software. Values were plotted as a smooth line graph with relative fluorescence intensity units (RFU) on the Y-axis, and the distance (nm) of each fluorescence signal was plotted as independent lines in the graph. 3 to 5 separate cells in each representative image field were quantified to determine the intensity profile pattern of each collected condition and time point.
Single-cell spread assays
Cells in suspension infected with a reporter PV-unaGpv virus variant (green). Infected cells were paired with stained (Vybrant DiD) uninfected cells (red) in isolated chambers of a multi-chamber microfluidics polydimethylsiloxane (PDMS) device as described (59, 103). In this study, this device was modified to harbor cell pairs (103). Fluorescence is monitored over time to detect an initial wave of infected cells expressing green fluorescence., yielding a yellow fluorescence overlay (see yellow cells). Spread was detected when a secondary wave of green fluorescence signal was observed in red-dyed cells, producing a colocalized yellow signal. Spread events were further extrapolated into no-spread, lytic spread, and non-lytic spread. In no spread, no secondary infection signal was detected after a primary cell green fluorescence signal. In lytic spread, the secondary infection signal arose after losing the primary cell green fluorescence (lysis). In non-lytic spread, the secondary infection signal was detected while green fluorescence was still present in the primary infected cell. HeLa or HAP1 cells were infected with either WT or F30Y PVunaGpv at an MOI of 5 and paired with uninfected stained cells (red).
For imaging, the microfluidics device was placed in the chamber of a WSKM GM2000 incubation system (Tokai, Japan), adapted to a Nikon Eclipse Ti inverted microscope (Nikon, Japan). Automatic bright-field and fluorescence imaging were performed every 30 minutes from 3 to 24 hpi with a ProScan II motorized flat top stage (Prior Scientific, USA), a CFI60 Plan Apochromat Lambda 10× objective, and a Hamamatsu C11440 camera. The fluorescence intensity of single cells and the background intensity of the microwells were extracted with a customized MATLAB script. Relative intensity was calculated as (Cell intensity - Background)/Background. No spread, lytic, and non-lytic events were quantified as percentages of the total events. The values were represented as mean ± standard error (SEM) from an n=3. Significant differences between conditions were noted based on a student’s t-test with p-values below 0.05.
Immunoblotting
Cells were lysed in radioimmunoprecipitation assay (RIPA) buffer containing an inhibitor cocktail of phenylmethylsulfonyl fluoride (PMSF) (1:100) (American Bioanalytical), Protease Inhibitor Cocktail (Sigma-Aldrich) (1:100), and Phosphatase Inhibitor Cocktail I (Abcam) (1:100). Lysates were collected and clarified by centrifugation. The lysate was mixed with 4× Laemmli buffer (Bio-Rad), boiled, and processed by SDS-PAGE. The samples were then transferred from the gel to a 20 μm nitrocellulose membrane (Bio-Rad) using the TurboBlot system (Bio-Rad). Membranes were blocked in Everyday Blocking Reagent (Bio-Rad) and probed with anti-LC3B (1:1000), anti-SQSTM1/p62 (1:1000), anti-VP2 (1:5000), or anti-tubulin (1:5000) antibodies overnight. Anti-rabbit or mouse-HRP was used as a secondary antibody at a 1:5000 dilution. Protein bands were visualized with the ECL detection system (Bio-Rad) using the ChemiDoc MP imaging system (Bio-Rad). Basic post-imaging editing and band quantification were performed using the Bio-Rad Image Lab software.
Scanning Transmission Electron Microscopy (STEM)
HeLa cells were infected, fixed, and embedded for TEM studies, as described previously (41). Briefly, cells were harvested and fixed with 1% glutaraldehyde, washed with 0.1 M cacodylate (sodium dimethyl arsenate, Electron Microscopy Sciences) twice for 5 min each, incubated in 1% reduced osmium tetroxide containing 1% potassium ferricyanide in 0.1 M cacodylate for 60 min in the dark with one exchange and washed two times with 0.1 M cacodylate again. En bloc staining was performed with 3% uranyl acetate in 50% ethanol for 60 min in the dark. Dehydration was carried out with varying ethanol concentrations (50, 70, 95, and 100% for 5–10 min) and 100% acetonitrile. Embedding was performed overnight with 100% Epon at 65° C. The embedded sample was sectioned with a diamond knife (DiATOME) to slice it to a 60–90 nm thickness using an ultramicrotome (Reichart-Jung). The sectioned sample was placed on a copper grid (Electron Microscopy Sciences) and stained with 2% uranyl acetate in 50% ethanol, followed by lead citrate staining for 12 min. The grid was washed with water and dried thoroughly.
HAADF-STEM (High Angle Annular Dark Field - Scanning Transmission Electron Microscopy) images were collected using a Thermo Scientific Talos F200X G2 (S)TEM operated at 200 kV and a beam current of approximately 0.12 nA. The Talos (S)TEM instrument has a resolution limit of 0.16nm in STEM mode, providing enhanced contrast compared to TEM (roughly proportional to Z^2). The contrast is also reversed when compared to TEM, with the vacuum appearing dark. Before STEM imaging, the grid square was first “beam showered” in TEM mode at a maximum beam current for approximately 10 minutes, with the beam spread to cover one entire grid square. This reduces the carbon contamination build-up that is naturally present on the surface of all samples (104). By beam showering, we lessen the contamination build-up that would otherwise limit contrast in the STEM image.
LC3-interacting region (LIR) predictions
LIR predictions were carried out as described by Jacomin et al., using the iLIR database (https://ilir.warwick.ac.uk) developed by the Nezis group at Warwick U.K (81). The consensus sequences of selected enteroviruses used in this analysis included: PV (Genbank:_V01149.1), CV-A16 (GenBank:_U05876.l), EV-71 (GenBank:_3U22521.1), CV-B3 (GenBank:_M88483.l), EV-D68 (GenBank:_AY426531.l), EV-E1 (GenBank:_D00214.1), EV-F1 (GenBank:_DQ092770.l), EV-G1 (GenBank:_AF363453.l), EV-H1 (GenBank:_AF201894.l), EV-J GenBank:_AF326766.2), HRV-A1 (GenBank:_FJ445111.l), HRV-B3 (GenBank:_DQ473485.l), HRV-C1 (GenBank:_EF077279.1), and HRV-B14 (GenBank:_U05876.l).
Protein structure analysis
PV 3C and 3D LC3 Interaction Regions (LIRs) were computationally scrutinized using AI and the Alphafold multimer server (82). The exposed consensus motif (W/F/Y) (x) (x) (L/I/V) within the LC3-interacting regions of 3C and 3D, as from their crystal structures, underwent structural analysis using PyMOL software (The PyMOL Molecular Graphics System, Version 2.0 Schrödinger, LLC). Thirteen LIRs within the 3CD protein were identified, and their sequences were verified for conservation through a Blast alignment of all Enteroviral sequences. Notably, two LIRs in the palm and thumb domain of the 3D structure were strictly conserved across multiple Enterovirus species.
Alphafold docking and binding
Complexes of PV 3D and LC3A/LC3B/Gabarap were made using the Alphafold multimer docking server, incorporating the sequences of 3D and LC3A/LC3B/Gabarap. Similar complexes were predicted for PV 3C and LC3A/LC3B/Gabarap. The five complex models generated by Alphafold underwent analysis for their scores and interface region, with the top model being energy minimized using the Yasara energy minimization server (83).
As from the best binding complexes identified, specific PV 3D LIR peptides in regions 30–34, namely LEPSAF(30)HYVFEGVK and F30Y variant LEPSAY(30)HYVFEGVK, along with LIR region 218–221 CDPDLFWSKIPVLM, were assessed for their binding affinities with LC3B. Peptide and LC3B Alphafold-multimer docking models were created, and the best model of the complex underwent energy minimization in Yasara. The computed DeltaG and Kd for the resulting complexes were deduced using the Prodigy software (105).
Molecular Dynamics Simulations
WT PV 3CD and F30Y PV 3CD MD simulations were performed using the AMBER software suite (106), applying parameters from amber forcefield 14SB (107). The 3CD WT monomer coordinates were extracted from the 3CD protein (PDB 2IJD) (39) crystal structure and prepared for simulations as described previously (28). The F30Y PV 3CD system was prepared in silico by replacing Phe at position-30 with Tyr; any steric clashes produced in the prepared mutant were removed by subsequent energy minimization and equilibration during MD simulations.
All-atom MD simulations were performed in explicit water (TIP3P model (108)); a minimal distance of 20 Å between the edge of the solvent box and any protein atoms was imposed. A cutoff radius of 12 Å was used to calculate non-bonded interactions with periodic boundary conditions applied; the particle mesh Ewald method (109, 110) was used to treat electrostatic interactions. The SHAKE algorithm (111) was employed to constrain hydrogens bonded to heavy atoms. The simulations were performed by first relaxing the systems in two cycles of energy minimization; subsequently, the systems were slowly heated to 300 K using the parallel version PMEMD under NVT conditions (constant volume and temperature). Langevin dynamics (112) with collision frequency (γ=2) were employed to regulate temperatures. The heated systems were then subjected to equilibration by running 100 ps of MD simulations under NPT conditions (constant pressure and temperature) with 1 fs integration time step. MD trajectories were collected over 200 ns at 1 ps interval and 2 fs integration time step. Analyses of the trajectories from MD simulations were done using the CPPTRAJ program (113). MD simulations were carried out on a multi-GPU workstation with 2x AMD EPYC 7702 64-core processor and 2x Nvidia RTX A5000.
Supplementary Material
IMPORTANCE.
PV and other enteroviruses hijack the cellular secretory autophagy pathway for non-lytic virus transmission. While much is known about the cellular factors required for non-lytic transmission, much less is known about viral factors contributing to transmission. We have discovered a PV nonstructural protein required for multiple steps of the pathway leading to vesicle-enclosed virions. This discovery should facilitate identification of the specific steps of the cellular secretory autophagy pathway and corresponding factors commandeered by the virus and may uncover novel targets for antiviral therapy.
ACKNOWLEDGMENTS
This work was supported by funding from the NIH NIAID R37AI053531, F31AI179022, and Burrough’s Wellcome Fund BWF1022057. Microscopy was performed at the UNC Hooker Imaging Core Facility, supported in part by P30 CA016086 Cancer Center Core Support Grant to the UNC Lineberger Comprehensive Cancer Center—special thanks to Director Wendy Salmon and EM Research Specialist Paul Risteff. The co-authors acknowledge the use of the Penn State Materials Characterization Lab and Huck Institutes of the Life Sciences Microscopy Core Facility. Special thanks to Director Grang Ning and EM sample specialist Missy Hazen.
REFERENCES
- 1.Andino R, Kirkegaard K, Macadam A, Racaniello VR, Rosenfeld AB. 2023. The Picornaviridae Family: Knowledge Gaps, Animal Models, Countermeasures, and Prototype Pathogens. J Infect Dis 228:S427–S445. [DOI] [PubMed] [Google Scholar]
- 2.Chumakov K, Ehrenfeld E, Agol VI, Wimmer E. 2021. Polio eradication at the crossroads. Lancet Glob Heal 9:e1172–e1175. [DOI] [PubMed] [Google Scholar]
- 3.Tebbens RJD, Kalkowska DA, Thompson KM. 2019. Global certification of wild poliovirus eradication: insights from modelling hard-to-reach subpopulations and confidence about the absence of transmission. BMJ Open 9:e023938. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Bigouette JP, Wilkinson AL, Tallis G, Burns CC, Wassilak SGF, Vertefeuille JF. 2021. Progress Toward Polio Eradication — Worldwide, January 2019–June 2021. Morb Mortal Wkly Rep 70:1129–1135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kalkowska DA, Wassilak SGF, Wiesen E, Burns CC, Pallansch MA, Badizadegan K, Thompson KM. 2023. Coordinated global cessation of oral poliovirus vaccine use: Options and potential consequences. Risk Anal 10.1111/risa.14158. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Cameron CE, Oh HS, Moustafa IM. 2010. Expanding knowledge of P3 proteins in the poliovirus lifecycle. Future Microbiol 5:867–881. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Ng KK- S, Arnold JJ, Cameron CE. 2008. RNA Interference. Curr Top Microbiol Immunol 320:137–156. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Oh HS, Banerjee S, Aponte-Diaz D, Sharma SD, Aligo J, Lodeiro MF, Ning G, Sharma R, Arnold JJ, Cameron CE. 2018. Multiple poliovirus-induced organelles suggested by comparison of spatiotemporal dynamics of membranous structures and phosphoinositides. Plos Pathog 14:e1007036. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Banerjee S, Aponte-Diaz D, Yeager C, Sharma SD, Ning G, Oh HS, Han Q, Umeda M, Hara Y, Wang RYL, Cameron CE. 2018. Hijacking of multiple phospholipid biosynthetic pathways and induction of membrane biogenesis by a picornaviral 3CD protein. Plos Pathog 14:e1007086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Richards OC, Ehrenfeld E. 1990. Poliovirus RNA Replication, p. 89–119. In. Springer Berlin Heidelberg. [DOI] [PubMed] [Google Scholar]
- 11.Jiang P, Liu Y, Ma H-C, Paul AV, Wimmer E. 2014. Picornavirus Morphogenesis. Microbiol Mol Biol R 78:418–437. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Racaniello VR. 2006. One hundred years of poliovirus pathogenesis. Virology 344:9–16. [DOI] [PubMed] [Google Scholar]
- 13.Jackson WT. 2014. Poliovirus-induced changes in cellular membranes throughout infection. Curr Opin Virol 9:67–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Bird SW, Kirkegaard K. 2015. Escape of non-enveloped virus from intact cells. Virology 479:444–449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Altan-Bonnet N, Perales C, Domingo E. 2019. Extracellular vesicles: vehicles of en bloc viral transmission. Virus Res 10.1016/j.virusres.2019.03.023. [DOI] [PubMed] [Google Scholar]
- 16.Kerviel A, Zhang M, Altan-Bonnet N. 2021. A New Infectious Unit: Extracellular Vesicles Carrying Virus Populations. Annu Rev Cell Dev Bi 37:1–27. [DOI] [PubMed] [Google Scholar]
- 17.Suhy DA, Giddings TH, Kirkegaard K. 2000. Remodeling the Endoplasmic Reticulum by Poliovirus Infection and by Individual Viral Proteins: an Autophagy-Like Origin for Virus-Induced Vesicles. J Virol 74:8953–8965. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Taylor MP, Kirkegaard K. 2007. Modification of Cellular Autophagy Protein LC3 by Poliovirus. J Virol 81:12543–12553. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Bird SW, Maynard ND, Covert MW, Kirkegaard K. 2014. Nonlytic viral spread enhanced by autophagy components. Proc National Acad Sci 111:13081–13086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Mutsafi Y, Altan-Bonnet N. 2018. Enterovirus Transmission by Secretory Autophagy. Viruses 10:139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Dahmane S, Kerviel A, Morado DR, Shankar K, Ahlman B, Lazarou M, Altan-Bonnet N, Carlson L-A. 2022. Membrane-assisted assembly and selective secretory autophagy of enteroviruses. Nat Commun 13:5986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Richards AL, Soares-Martins JAP, Riddell GT, Jackson WT. 2014. Generation of Unique Poliovirus RNA Replication Organelles. Mbio 5:e00833–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Dahmane S, Shankar K, Carlson L-A. 2022. A 3D view of how enteroviruses hijack autophagy. Autophagy 1–3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Abernathy E, Mateo R, Majzoub K, Buuren N van, Bird SW, Carette JE, Kirkegaard K. 2019. Differential and convergent utilization of autophagy components by positive-strand RNA viruses. Plos Biol 17:e2006926. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Jassey A, Jackson WT. 2023. Viruses and autophagy: bend, but don’t break. Nat Rev Microbiol 1–13. [DOI] [PubMed] [Google Scholar]
- 26.Moustafa IM, Shen H, Morton B, Colina CM, Cameron CE. 2011. Molecular Dynamics Simulations of Viral RNA Polymerases Link Conserved and Correlated Motions of Functional Elements to Fidelity. J Mol Biol 410:159–181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Moustafa IM, Korboukh VK, Arnold JJ, Smidansky ED, Marcotte LL, Gohara DW, Yang X, Sánchez-Farrán MA, Filman D, Maranas JK, Boehr DD, Hogle JM, Colina CM, Cameron CE. 2014. Structural Dynamics as a Contributor to Error-prone Replication by an RNA-dependent RNA Polymerase*. J Biol Chem 289:36229–36248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Moustafa IM, Gohara DW, Uchida A, Yennawar N, Cameron CE. 2015. Conformational Ensemble of the Poliovirus 3CD Precursor Observed by MD Simulations and Confirmed by SAXS: A Strategy to Expand the Viral Proteome? Viruses 7:5962–5986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Arnold JJ, Cameron CE. 2000. Poliovirus RNA-dependent RNA Polymerase (3Dpol) ASSEMBLY OF STABLE, ELONGATION-COMPETENT COMPLEXES BY USING A SYMMETRICAL PRIMER-TEMPLATE SUBSTRATE (sym/sub)*. J Biol Chem 275:5329–5336. [DOI] [PubMed] [Google Scholar]
- 30.Dulin D, Arnold JJ, Laar T van, Oh H-S, Lee C, Perkins AL, Harki DA, Depken M, Cameron CE, Dekker NH. 2017. Signatures of Nucleotide Analog Incorporation by an RNA-Dependent RNA Polymerase Revealed Using High-Throughput Magnetic Tweezers. Cell Rep 21:1063–1076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Götte M, Rausch JW, Marchand B, Sarafianos S, Grice SFJL. 2010. Reverse transcriptase in motion: Conformational dynamics of enzyme–substrate interactions. Biochim Biophys Acta (BBA) - Proteins Proteom 1804:1202–1212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Menéndez-Arias L, Sebastián-Martín A, Álvarez M. 2017. Viral reverse transcriptases. Virus Res 234:153–176. [DOI] [PubMed] [Google Scholar]
- 33.Wyman C, Botchan M. 1995. DNA Replication: A familiar ring to DNA polymerase processivity. Curr Biol 5:334–337. [DOI] [PubMed] [Google Scholar]
- 34.Johansson E, Dixon N. 2013. Replicative DNA Polymerases. Cold Spring Harb Perspect Biol 5:a012799. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Mulye M, Singh MI, Jain V. 2022. From Processivity to Genome Maintenance: The Many Roles of Sliding Clamps. Genes 13:2058. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Lawson MA, Semler BL. 1992. Alternate poliovirus nonstructural protein processing cascades generated by primary sites of 3C proteinase cleavage. Virology 191:309–320. [DOI] [PubMed] [Google Scholar]
- 37.Pathak HB, Oh HS, Goodfellow IG, Arnold JJ, Cameron CE. 2008. Picornavirus Genome Replication ROLES OF PRECURSOR PROTEINS AND RATE-LIMITING STEPS IN oriI-DEPENDENT VPg URIDYLYLATION*. J Biol Chem 283:30677–30688. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Belov GA, Fogg MH, Ehrenfeld E. 2005. Poliovirus Proteins Induce Membrane Association of GTPase ADP-Ribosylation Factor. J Virol 79:7207–7216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Marcotte LL, Wass AB, Gohara DW, Pathak HB, Arnold JJ, Filman DJ, Cameron CE, Hogle JM. 2007. Crystal Structure of Poliovirus 3CD Protein: Virally Encoded Protease and Precursor to the RNA-Dependent RNA Polymerase. J Virol 81:3583–3596. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Belov GA, Habbersett C, Franco D, Ehrenfeld E. 2007. Activation of Cellular Arf GTPases by Poliovirus Protein 3CD Correlates with Virus Replication. J Virol 81:9259–9267. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Oh HS, Pathak HB, Goodfellow IG, Arnold JJ, Cameron CE. 2009. Insight into Poliovirus Genome Replication and Encapsidation Obtained from Studies of 3B-3C Cleavage Site Mutants. J Virol 83:9370–9387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Franco D, Pathak HB, Cameron CE, Rombaut B, Wimmer E, Paul AV. 2005. Stimulation of poliovirus RNA synthesis and virus maturation in a HeLa cell-free in vitro translation-RNA replication system by viral protein 3CDpro. Virol J 2:86. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Pincus SE, Diamond DC, Emini EA, Wimmer E. 1986. Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C. J Virol 57:638–646. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Barton DJ, Flanegan JB. 1997. Synchronous replication of poliovirus RNA: initiation of negative-strand RNA synthesis requires the guanidine-inhibited activity of protein 2C. J Virol 71:8482–8489. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Pfister T, Wimmer E. 1999. Characterization of the Nucleoside Triphosphatase Activity of Poliovirus Protein 2C Reveals a Mechanism by Which Guanidine Inhibits Poliovirus Replication*. J Biol Chem 274:6992–7001. [DOI] [PubMed] [Google Scholar]
- 46.Vance LM, Moscufo N, Chow M, Heinz BA. 1997. Poliovirus 2C region functions during encapsidation of viral RNA. J Virol 71:8759–8765. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Verlinden Y, Cuconati A, Wimmer E, Rombaut B. 2000. The antiviral compound 5-(3,4-dichlorophenyl) methylhydantoin inhibits the post-synthetic cleavages and the assembly of poliovirus in a cell-free system. Antivir Res 48:61–69. [DOI] [PubMed] [Google Scholar]
- 48.Tijsma A, Thibaut HJ, Franco D, Dallmeier K, Neyts J. 2016. Hydantoin: The mechanism of its in vitro anti-enterovirus activity revisited. Antivir Res 133:106–109. [DOI] [PubMed] [Google Scholar]
- 49.Crotty S, Saleh M-C, Gitlin L, Beske O, Andino R. 2004. The Poliovirus Replication Machinery Can Escape Inhibition by an Antiviral Drug That Targets a Host Cell Protein. J Virol 78:3378–3386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Jackson CA, Cobbs C, Peduzzi JD, Novak M, Morrow CD. 2001. Repetitive Intrathecal Injections of Poliovirus Replicons Result in Gene Expression in Neurons of the Central Nervous System Without Pathogenesis. Hum Gene Ther 12:1827–1841. [DOI] [PubMed] [Google Scholar]
- 51.Liu W, Caglar MU, Mao Z, Woodman A, Arnold JJ, Wilke CO, Cameron CE. 2019. More than efficacy revealed by single-cell analysis of antiviral therapeutics. Sci Adv 5:eaax4761. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Kouiavskaia D, Chen Z, Dragunsky E, Mirochnitchenko O, Purcell R, Chumakov K. 2015. A single chimpanzee-human neutralizing monoclonal antibody provides post-exposure protection against type 1 and type 2 polioviruses. J Clin Virol 65:32–37. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Ulbrandt ND, Ji H, Patel NK, Riggs JM, Brewah YA, Ready S, Donacki NE, Folliot K, Barnes AS, Senthil K, Wilson S, Chen M, Clarke L, MacPhail M, Li J, Woods RM, Coelingh K, Reed JL, McCarthy MP, Pfarr DS, Osterhaus ADME, Fouchier RAM, Kiener PA, Suzich JA. 2006. Isolation and Characterization of Monoclonal Antibodies Which Neutralize Human Metapneumovirus In Vitro and In Vivo. J Virol 80:7799–7806. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Adeyemi OO, Nicol C, Stonehouse NJ, Rowlands DJ. 2017. Increasing Type 1 Poliovirus Capsid Stability by Thermal Selection. J Virol 91:e01586–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Chen Z, Fischer ER, Kouiavskaia D, Hansen BT, Ludtke SJ, Bidzhieva B, Makiya M, Agulto L, Purcell RH, Chumakov K. 2013. Cross-neutralizing human anti-poliovirus antibodies bind the recognition site for cellular receptor. Proc Natl Acad Sci 110:20242–20247. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Charnesky AJ, Faust JE, Lee H, Puligedda RD, Goetschius DJ, DiNunno NM, Thapa V, Bator CM, Cho SH (Joseph), Wahid R, Mahmood K, Dessain S, Chumakov KM, Rosenfeld A, Hafenstein SL. 2023. A human monoclonal antibody binds within the poliovirus receptor-binding site to neutralize all three serotypes. Nat Commun 14:6335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Sherry L, Grehan K, Snowden JS, Knight ML, Adeyemi OO, Rowlands DJ, Stonehouse NJ. 2020. Comparative Molecular Biology Approaches for the Production of Poliovirus Virus-Like Particles Using Pichia pastoris. Msphere 5:e00838–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Sherry L, Swanson JJ, Grehan K, Xu H, Uchida M, Jones IM, Stonehouse NJ, Rowlands DJ. 2022. Protease-Independent Production of Poliovirus Virus-like Particles in Pichia pastoris: Implications for Efficient Vaccine Development and Insights into Capsid Assembly. Microbiol Spectr 11:e04300–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Guo F, Li S, Caglar MU, Mao Z, Liu W, Woodman A, Arnold JJ, Wilke CO, Huang TJ, Cameron CE. 2017. Single-Cell Virology: On-Chip Investigation of Viral Infection Dynamics. Cell Rep 21:1692–1704. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Das A, Rivera-Serrano EE, Yin X, Walker CM, Feng Z, Lemon SM. 2023. Cell entry and release of quasi-enveloped human hepatitis viruses. Nat Rev Microbiol 1–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Belov GA, Altan-Bonnet N, Kovtunovych G, Jackson CL, Lippincott-Schwartz J, Ehrenfeld E. 2006. Hijacking Components of the Cellular Secretory Pathway for Replication of Poliovirus RNA. J Virol 81:558–567. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Melia TJ, Lystad AH, Simonsen A. 2020. Autophagosome biogenesis: From membrane growth to closure. J Cell Biol 219:e202002085. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Lamark T, Johansen T. 2021. Mechanisms of Selective Autophagy. Annu Rev Cell Dev Bi 37:1–27. [DOI] [PubMed] [Google Scholar]
- 64.Gómez-Virgilio L, Silva-Lucero M-C, Flores-Morelos D-S, Gallardo-Nieto J, Lopez-Toledo G, Abarca-Fernandez A-M, Zacapala-Gómez A-E, Luna-Muñoz J, Montiel-Sosa F, Soto-Rojas LO, Pacheco-Herrero M, Cardenas-Aguayo M-C. 2022. Autophagy: A Key Regulator of Homeostasis and Disease: An Overview of Molecular Mechanisms and Modulators. Cells 11:2262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Ichimura Y, Kominami E, Tanaka K, Komatsu M. 2008. Selective turnover of p62/A170/SQSTM1 by autophagy. Autophagy 4:1063–1066. [DOI] [PubMed] [Google Scholar]
- 66.Johansen T, Lamark T. 2011. Selective autophagy mediated by autophagic adapter proteins. Autophagy 7:279–296. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Schaaf MBE, Keulers TG, Vooijs MA, Rouschop KMA. 2016. LC3/GABARAP family proteins: autophagy-(un)related functions. Faseb J 30:3961–3978. [DOI] [PubMed] [Google Scholar]
- 68.Leidal AM, Huang HH, Marsh T, Solvik T, Zhang D, Ye J, Kai F, Goldsmith J, Liu JY, Huang Y-H, Monkkonen T, Vlahakis A, Huang EJ, Goodarzi H, Yu L, Wiita AP, Debnath J. 2020. The LC3-conjugation machinery specifies the loading of RNA-binding proteins into extracellular vesicles. Nat Cell Biol 1–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Graef M. 2020. Recent advances in the understanding of autophagosome biogenesis. F1000research 9:F1000 Faculty Rev-212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Birgisdottir ÅB, Lamark T, Johansen T. 2013. The LIR motif – crucial for selective autophagy. J Cell Sci 126:3237–3247. [DOI] [PubMed] [Google Scholar]
- 71.Wirth M, Zhang W, Razi M, Nyoni L, Joshi D, O’Reilly N, Johansen T, Tooze SA, Mouilleron S. 2019. Molecular determinants regulating selective binding of autophagy adapters and receptors to ATG8 proteins. Nat Commun 10:2055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Popelka H, Klionsky DJ. 2015. Analysis of the native conformation of the LIR/AIM motif in the Atg8/LC3/GABARAP-binding proteins. Autophagy 11:2153–2159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Ponpuak M, Mandell MA, Kimura T, Chauhan S, Cleyrat C, Deretic V. 2015. Secretory autophagy. Curr Opin Cell Biol 35:106–116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Corona AK, Jackson WT. 2018. Finding the Middle Ground for Autophagic Fusion Requirements. Trends Cell Biol 28:869–881. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Ganesan D, Cai Q. 2021. Understanding amphisomes. Biochem J 478:1959–1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Xu J, Camfield R, Gorski SM. 2018. The interplay between exosomes and autophagy – partners in crime. J Cell Sci 131:jcs215210. [DOI] [PubMed] [Google Scholar]
- 77.Hassanpour M, Rezabakhsh A, Rezaie J, Nouri M, Rahbarghazi R. 2020. Exosomal cargos modulate autophagy in recipient cells via different signaling pathways. Cell Biosci 10:92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Baeken MW, Weckmann K, Diefenthäler P, Schulte J, Yusifli K, Moosmann B, Behl C, Hajieva P. 2020. Novel Insights into the Cellular Localization and Regulation of the Autophagosomal Proteins LC3A, LC3B and LC3C. Cells 9:2315. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Giddings TH. 2003. Freeze-substitution protocols for improved visualization of membranes in high-pressure frozen samples. J Microsc-oxford 212:53–61. [DOI] [PubMed] [Google Scholar]
- 80.Yang JE, Rossignol ED, Chang D, Zaia J, Forrester I, Raja K, Winbigler H, Nicastro D, Jackson WT, Bullitt E. 2020. Complexity and ultrastructure of infectious extracellular vesicles from cells infected by non-enveloped virus. Sci Rep-uk 10:7939. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Kalvari I, Tsompanis S, Mulakkal NC, Osgood R, Johansen T, Nezis IP, Promponas VJ. 2014. iLIR. Autophagy 10:913–925. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Liu J, Guo Z, Wu T, Roy RS, Quadir F, Chen C, Cheng J. 2023. Enhancing alphafold-multimer-based protein complex structure prediction with MULTICOM in CASP15. Commun Biol 6:1140. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Krieger E, Joo K, Lee J, Lee J, Raman S, Thompson J, Tyka M, Baker D, Karplus K. 2009. Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: Four approaches that performed well in CASP8. Proteins: Struct, Funct, Bioinform 77:114–122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Winston DS, Boehr DD. 2021. The Picornavirus Precursor 3CD Has Different Conformational Dynamics Compared to 3Cpro and 3Dpol in Functionally Relevant Regions. Viruses 13:442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Lan Y, Leur SW van, Fernando JA, Wong HH, Kampmann M, Siu L, Zhang J, Li M, Nicholls JM, Sanyal S. 2023. Viral subversion of selective autophagy is critical for biogenesis of virus replication organelles. Nat Commun 14:2698. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Altan-Bonnet N. 2016. Extracellular vesicles are the Trojan horses of viral infection. Curr Opin Microbiol 32:77–81. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Suhy DA, Giddings TH, Kirkegaard K. 2000. Remodeling the Endoplasmic Reticulum by Poliovirus Infection and by Individual Viral Proteins: an Autophagy-Like Origin for Virus-Induced Vesicles. J Virol 74:8953–8965. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Corona AK, Saulsbery HM, Velazquez AFC, Jackson WT. 2018. Enteroviruses Remodel Autophagic Trafficking through Regulation of Host SNARE Proteins to Promote Virus Replication and Cell Exit. Cell Reports 22:3304–3314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Zimina A, Viktorova EG, Moghimi S, Nchoutmboube J, Belov GA. 2021. Interaction of Poliovirus Capsid Proteins with the Cellular Autophagy Pathway. Viruses 13:1587. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Cho MW, Teterina N, Egger D, Bienz K, Ehrenfeld E. 1994. Membrane Rearrangement and Vesicle Induction by Recombinant Poliovirus 2C and 2BC in Human Cells. Virology 202:129–145. [DOI] [PubMed] [Google Scholar]
- 91.Hsu N-Y, Ilnytska O, Belov G, Santiana M, Chen Y-H, Takvorian PM, Pau C, Schaar H van der, Kaushik-Basu N, Balla T, Cameron CE, Ehrenfeld E, Kuppeveld FJM van, Altan-Bonnet N. 2010. Viral Reorganization of the Secretory Pathway Generates Distinct Organelles for RNA Replication. Cell 141:799–811. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Li X, Wang M, Cheng A, Wen X, Ou X, Mao S, Gao Q, Sun D, Jia R, Yang Q, Wu Y, Zhu D, Zhao X, Chen S, Liu M, Zhang S, Liu Y, Yu Y, Zhang L, Tian B, Pan L, Chen X. 2020. Enterovirus Replication Organelles and Inhibitors of Their Formation. Front Microbiol 11:1817. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Rossignol ED, Yang JE, Bullitt E. 2015. The Role of Electron Microscopy in Studying the Continuum of Changes in Membranous Structures during Poliovirus Infection. Viruses 7:5305–5318. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Sweeney TR, Cisnetto V, Bose D, Bailey M, Wilson JR, Zhang X, Belsham GJ, Curry S. 2010. Foot-and-Mouth Disease Virus 2C Is a Hexameric AAA+ Protein with a Coordinated ATP Hydrolysis Mechanism. J Biol Chem 285:24347–24359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Adams P, Kandiah E, Effantin G, Steven AC, Ehrenfeld E. 2009. Poliovirus 2C Protein Forms Homo-oligomeric Structures Required for ATPase Activity*. J Biol Chem 284:22012–22021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Papageorgiou N, Coutard B, Lantez V, Gautron E, Chauvet O, Baronti C, Norder H, Lamballerie XD, Heresanu V, Ferté N, Veesler S, Gorbalenya AE, Canard B. 2010. The 2C putative helicase of echovirus 30 adopts a hexameric ring-shaped structure. Acta Crystallogr Sect D 66:1116–1120. [DOI] [PubMed] [Google Scholar]
- 97.Teterina NL, Bienz K, Egger D, Gorbalenya AE, Ehrenfeld E. 1997. Induction of Intracellular Membrane Rearrangements by HAV Proteins 2C and 2BC. Virology 237:66–77. [DOI] [PubMed] [Google Scholar]
- 98.Liu Y, Wang C, Mueller S, Paul AV, Wimmer E, Jiang P. 2010. Direct Interaction between Two Viral Proteins, the Nonstructural Protein 2CATPase and the Capsid Protein VP3, Is Required for Enterovirus Morphogenesis. Plos Pathog 6:e1001066. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Asare E, Mugavero J, Jiang P, Wimmer E, Paul AV. 2016. A Single Amino Acid Substitution in Poliovirus Nonstructural Protein 2CATPase Causes Conditional Defects in Encapsidation and Uncoating. J Virol 90:6174–6186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Chen Y-H, Du W, Hagemeijer MC, Takvorian PM, Pau C, Cali A, Brantner CA, Stempinski ES, Connelly PS, Ma H-C, Jiang P, Wimmer E, Altan-Bonnet G, Altan-Bonnet N. 2015. Phosphatidylserine Vesicles Enable Efficient En Bloc Transmission of Enteroviruses. Cell 160:619–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Harris KS, Reddigari SR, Nicklin MJ, Hämmerle T, Wimmer E. 1992. Purification and characterization of poliovirus polypeptide 3CD, a proteinase and a precursor for RNA polymerase. J Virol 66:7481–7489. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Shengjuler D, Chan YM, Sun S, Moustafa IM, Li Z-L, Gohara DW, Buck M, Cremer PS, Boehr DD, Cameron CE. 2017. The RNA-Binding Site of Poliovirus 3C Protein Doubles as a Phosphoinositide-Binding Domain. Structure 25:1875–1886.e7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Liu W, Wilke CO, Arnold JJ, Sotoudegan MS, Cameron CE. 2024. Single-cell virology: On-chip, quantitative characterization of the dynamics of virus spread from one single cell to another. bioRxiv 2024.09.25.615011. [DOI] [PubMed] [Google Scholar]
- 104.Mitchell DRG. 2015. Contamination mitigation strategies for scanning transmission electron microscopy. Micron 73:36–46. [DOI] [PubMed] [Google Scholar]
- 105.Xue LC, Rodrigues JP, Kastritis PL, Bonvin AM, Vangone A. 2016. PRODIGY: a web server for predicting the binding affinity of protein–protein complexes. Bioinformatics 32:3676–3678. [DOI] [PubMed] [Google Scholar]
- 106.Case D.A., Ben-Shalom I.Y., Brozell S.R., Cerutti D.S., Cheatham T.E. III, Cruzeiro V.W.D., Darden T.A., Duke R.E., Ghoreishi D., Gilson M.K., Gohlke H., Goetz A.W., Greene D., Harris R, Homeyer N., Huang Y, S Izadi, Kovalenko A, Kurtzman T, Lee T.S, LeGrand S., Li P., Lin C., Liu J., Luchko T., Luo R., DJ Mermelstein, Merz K.M., Miao Y., Monard G, Nguyen C, Nguyen H, Omelyan I, Onufriev A., Pan F., R Qi, Roe D.R., Roitberg A., Sagui C., Schott-Verdugo S, Shen J., Simmerling C.L, Smith J, SalomonFerrer R, Swails J., Walker R.C., Wang J., Wei H, Wolf R.M., Wu X., Xiao L., Yorkand D.M. Kollman P.A.. 2018. AMBER2018. University of California, San Francisco. [Google Scholar]
- 107.Maier JA, Martinez C, Kasavajhala K, Wickstrom L, Hauser KE, Simmerling C. 2015. ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. J Chem Theory Comput 11:3696–3713. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML. 1983. Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926–935. [Google Scholar]
- 109.Darden T, York D, Pedersen L. 1993. Particle mesh Ewald: An N ·log( N ) method for Ewald sums in large systems. J Chem Phys 98:10089–10092. [Google Scholar]
- 110.Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG. 1995. A smooth particle mesh Ewald method. J Chem Phys 103:8577–8593. [Google Scholar]
- 111.Ryckaert J-P, Ciccotti G, Berendsen HJC. 1977. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J Comput Phys 23:327–341. [Google Scholar]
- 112.Feller SE, Zhang Y, Pastor RW, Brooks BR. 1995. Constant pressure molecular dynamics simulation: The Langevin piston method. J Chem Phys 103:4613–4621. [Google Scholar]
- 113.Roe DR, Cheatham TE. 2013. PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. J Chem Theory Comput 9:3084–3095. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.